Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ

$4.60

$+0.76

(+19.87%)

Pre-Market

Galmed Pharmaceuticals Ltd. (GLMD) Live Price Chart

Last updated: ⁦2026-09-16 13:20:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Galmed Pharmaceuticals Ltd. (GLMD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $4.60, with a market capitalisation of $4.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.29 to $13.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.95M
Open	$3.84
Day's High	$38,966.40
Day's Low	$3.29
Previous Close	$3.83
Volume	105.99K
Average Volume	61.39K
P/E Ratio	--
52-Week High	$13.20
52-Week Low	$3.29
Dividend Yield	--
Earnings Date	--

Galmed Pharmaceuticals Ltd. (GLMD) Pre-Market Stock Price

Galmed Pharmaceuticals Ltd. (GLMD) is trading at $3.82 in pre-market trading as of 2026-09-09 23:57:00, down 0.26% ($0.01) from the previous close of $3.83

Pre-market trading shows how investors are pricing GLMD before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Galmed Pharmaceuticals Ltd. (GLMD) 7-Day Stock Price Change

Over the past seven days, Galmed Pharmaceuticals Ltd. (GLMD) moved from $4.12 to $4.60, representing a gain of 11.53% ($0.47).

The stock traded between $3.74 and $4.63 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 54.49 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

GLMD 52-Week Price Position

Position in Range: 13.2%

52W Low$3.29

52W High$13.20

GLMD is currently trading at $4.60, placing it 13.2% of the way from its 52-week low of $3.29 to its 52-week high of $13.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Galmed Pharmaceuticals Ltd. (GLMD)?

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Galmed Pharmaceuticals Ltd. Information

Employees	6
Exchange	NASDAQ
Company Website	https://www.galmedpharma.com

How to Buy Galmed Pharmaceuticals Ltd. (GLMD) Stock on MEXC

Eligible investors can buy real shares of Galmed Pharmaceuticals Ltd. (GLMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GLMD and Place Your Order

Open the RealStocks trading page and search for GLMD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Galmed Pharmaceuticals Ltd. (GLMD) stock price today?

Galmed Pharmaceuticals Ltd. (GLMD) is currently trading at $ 4.60, up 20.13% ($0.77) from the previous close of $ 3.83. Intraday prices update in real time during regular trading hours.

2.Is GLMD stock going up or down today?

As of 2026-09-09 23:57:00, GLMD is trading at $ 4.60, up 20.13% ($0.77) from its previous close of $ 3.83. The stock has traded between $ 3.29 and $ 38,966.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is GLMD pre-market price?

As of 2026-09-09 23:57:00, GLMD is trading at $ 3.82 in pre-market trading, down 0.26% ($0.01) from the previous close of $ 3.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GLMD after-hours price?

As of 2026-09-09 23:57:00, GLMD is trading at $ 4.59 in after-hours trading, up 20.00% ($0.76) from the regular-session close of $ 3.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GLMD stock trading now?

GLMD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GLMD sit relative to its 52-week high and low?

Over the past 52 weeks, GLMD has traded between a low of $ 3.29 and a high of $ 13.20. At $ 4.60, the stock is positioned 13.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Galmed Pharmaceuticals Ltd. in?

Galmed Pharmaceuticals Ltd. (GLMD) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Galmed Pharmaceuticals Ltd.'s market capitalisation and where is it listed?

Galmed Pharmaceuticals Ltd. is listed on the NASDAQ exchange with a market capitalisation of $ 4.95M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GLMD valued in terms of P/E ratio and EPS?

GLMD trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Galmed Pharmaceuticals Ltd. pay a dividend?

Galmed Pharmaceuticals Ltd. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.